A Silicon Valley-based CEO has shifted her focus from biotechnology to Assyrian arts and is producing an opera to keep her Assyrian heritage alive.
Nora Lacey, CEO of biotech company Cell Marque Corporation, told EpochTV’s “Bay Area Innovators” program about her journey and decision.
